• LAST PRICE
    24.9000
  • TODAY'S CHANGE (%)
    Trending Up0.3500 (1.4257%)
  • Bid / Lots
    20.0000/ 1
  • Ask / Lots
    27.1500/ 9
  • Open / Previous Close
    24.6000 / 24.5500
  • Day Range
    Low 24.0900
    High 24.9700
  • 52 Week Range
    Low 12.5400
    High 28.9100
  • Volume
    205,077
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 24.55
TimeVolumeBCYC
09:32 ET17824.6
09:36 ET219924.73
09:38 ET110024.35
09:39 ET15024.45
09:43 ET120024.25
09:45 ET30024.44
09:48 ET20024.6
09:54 ET60024.44
09:56 ET99924.41
10:01 ET20024.255
10:03 ET20024.25
10:06 ET10024.25
10:08 ET90024.26
10:10 ET20024.25
10:12 ET10024.095
10:14 ET20024.09
10:15 ET20024.16
10:17 ET100024.37
10:19 ET10024.28
10:21 ET60024.37
10:24 ET20024.295
10:26 ET120024.45
10:28 ET25024.45
10:30 ET10024.275
10:33 ET30024.27
10:35 ET20024.165
10:37 ET70024.34
10:39 ET369124.23
10:42 ET10024.25
10:44 ET20024.28
10:46 ET30024.38
10:50 ET10024.295
10:51 ET110024.37
10:53 ET50024.3905
10:55 ET40524.45
10:57 ET10024.565
11:00 ET100024.79
11:09 ET20024.755
11:11 ET20024.63
11:13 ET10024.635
11:15 ET30024.695
11:18 ET20024.76
11:20 ET10024.67
11:22 ET10024.665
11:24 ET30024.755
11:27 ET10024.685
11:29 ET10024.69
11:31 ET24124.705
11:36 ET60024.7
11:38 ET110024.7
11:40 ET670024.725
11:42 ET30024.725
11:44 ET40024.655
11:45 ET1030024.81
11:47 ET60024.83
11:49 ET30024.82
11:51 ET170024.82
11:54 ET50024.845
11:56 ET133024.845
11:58 ET50024.785
12:00 ET30024.7506
12:02 ET169924.76
12:03 ET318824.77
12:05 ET270024.75
12:07 ET308624.77
12:12 ET82224.785
12:14 ET30024.79
12:16 ET10024.775
12:18 ET316124.765
12:21 ET30024.77
12:23 ET20024.765
12:25 ET20024.76
12:27 ET110024.75
12:30 ET10024.75
12:32 ET10024.665
12:34 ET50024.705
12:36 ET70024.735
12:39 ET30024.665
12:41 ET30024.695
12:43 ET10024.65
12:45 ET40024.66
12:48 ET20024.5
12:50 ET234524.71
12:52 ET59024.78
12:54 ET61324.81
12:57 ET10024.785
12:59 ET139224.8
01:01 ET225824.75
01:03 ET10024.725
01:08 ET20024.75
01:14 ET20024.73
01:15 ET90024.835
01:17 ET60024.725
01:19 ET20024.76
01:21 ET30024.75
01:30 ET39224.7
01:32 ET30024.69
01:35 ET10024.63
01:37 ET10024.685
01:42 ET10024.64
01:44 ET211224.75
01:46 ET20024.75
01:48 ET288424.75
01:50 ET20024.79
01:51 ET70124.8
01:55 ET115624.8
02:08 ET10024.725
02:09 ET10024.7425
02:11 ET140024.8
02:13 ET40024.715
02:15 ET20024.81
02:18 ET31024.775
02:20 ET40024.775
02:24 ET154224.845
02:26 ET50024.845
02:29 ET10024.845
02:36 ET20024.85
02:38 ET10024.85
02:40 ET20024.8
02:42 ET10024.78
02:44 ET10024.835
02:47 ET10024.79
02:49 ET20024.835
02:51 ET20024.835
02:54 ET10024.79
02:56 ET20024.78
02:58 ET60024.795
03:00 ET188224.85
03:02 ET37524.85
03:03 ET20024.79
03:07 ET10024.85
03:09 ET20024.855
03:12 ET432824.84
03:14 ET10024.865
03:16 ET70024.9
03:18 ET50024.81
03:20 ET30024.86
03:21 ET40024.86
03:23 ET10024.86
03:27 ET40024.85
03:32 ET140024.74
03:36 ET70024.805
03:38 ET20024.81
03:39 ET40024.81
03:41 ET10024.81
03:43 ET10024.74
03:45 ET211924.84
03:48 ET168624.795
03:50 ET80024.825
03:52 ET430024.86
03:54 ET180024.945
03:56 ET1054324.94
03:57 ET412324.9
03:59 ET1058524.9
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBCYC
Bicycle Therapeutics PLC
1.0B
-4.9x
---
United StatesRLAY
Relay Therapeutics Inc
1.1B
-3.0x
---
United StatesSSII
SS Innovations International Inc
1.0B
-46.4x
---
United StatesVERV
Verve Therapeutics Inc
1.1B
-4.2x
---
United StatesKYTX
Kyverna Therapeutics Inc
1.0B
-17.9x
---
United StatesETNB
89Bio Inc
1.1B
-5.8x
---
As of 2024-03-28

Company Information

Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a class of medicines, which it refers to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are therapeutic modality combining the pharmacology usually associated with a biologic with the manufacturing and pharmacokinetic properties of a small molecule. Its product candidates BT5528, BT8009 and BT1718, are each a Bicycle Toxin Conjugate (BTC). BT5528 is a second-generation BTC designed to target Ephrin type A receptor 2 (EphA2). BT8009 is a second-generation BTC designed to target Nectin-4, a validated tumor antigen. BT1718 is being developed to target tumors that express Membrane Type 1 matrix metalloproteinase (MT1 MMP). Its product candidates BT7480 and BT7455, are each a Bicycle tumor-targeted immune cell agonist (TICA). The Company is also focused on additional therapeutic areas other than its wholly owned oncology portfolio.

Contact Information

Headquarters
Babraham HallCAMBRIDGE, United Kingdom CB21 6GS
Phone
122-326-1503
Fax
---

Executives

Non-Executive Chairman of the Board
Pierre Legault
Chief Executive Officer, Executive Director
Kevin Lee
Chief Financial Officer, Principal Financial Officer
Alethia Young
Chief Operating Officer
Alistair Milnes
Chief Technology Officer
Michael Skynner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.0B
Revenue (TTM)
$27.0M
Shares Outstanding
42.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.89
EPS
$-5.13
Book Value
$8.74
P/E Ratio
-4.9x
Price/Sales (TTM)
38.8
Price/Cash Flow (TTM)
---
Operating Margin
-704.13%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.